Amgen News

Amgen | DEFA14A: Others

16:13 ET

Amgen | DEFA14A: Others

Apr 17 16:10 ET

Amgen | DEF 14A: Definitive information statements

Apr 17 16:06 ET

Amgen | 8-K: AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

Feb 6 16:24 ET

Amgen | 8-K: Amgen Announces Executive Appointments to Accelerate Innovation

Dec 14, 2023 09:16 ET

Amgen | 8-K: Amgen Reports Third Quarter Financial Results

Oct 31, 2023 07:15 ET

Amgen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Oct 6, 2023 16:35 ET

Amgen | 8-K: Amgen Completes Acquisition of Horizon Therapeutics Plc

Oct 6, 2023 16:01 ET

Amgen | 8-K: On October 5, 2023, the High Court of Ireland sanctioned the acquire Scheme

Oct 5, 2023 07:43 ET

Amgen | 8-K: Amgen Inc.、Pillartree Limited entered into certain Transaction Agreement with Horizon Therapeutics plc

Sep 12, 2023 07:30 ET

Amgen | 8-K: The Irish High Court set a court hearing for October 5, 2023 to consider Horizon’s application for sanction of the proposed scheme of arrangement to effect the Acquisition under Irish law.

Sep 5, 2023 09:12 ET

Amgen | 8-K: AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

Sep 1, 2023 09:25 ET

Amgen | 8-K: The Board of Directors of Amgen Inc. appointed Matthew C. Busch as Vice President, Finance and Chief Accounting Officer

Aug 3, 2023 17:48 ET

Amgen | 8-K: Amgen REPORTS SECOND QUARTER FINANCIAL RESULTS

Aug 3, 2023 16:12 ET

Amgen | 8-K: Amgen, Horizon Therapeutics Plc and Pillartree Limited, A Wholly Owned Subsidiary of Amgen Entered into a Transaction Agreement

Jun 5, 2023 08:00 ET

Amgen | 8-K: Poll Results of Amgen Meeting

May 22, 2023 17:23 ET

Amgen | 8-K: Entered into a Transaction Agreement

May 18, 2023 08:29 ET

Amgen | 8-K: Amgen Proposed Acquisition of Horizon Therapeutics

May 16, 2023 17:28 ET

Amgen | DEFA14A: Others

May 3, 2023 06:05 ET

Amgen | 8-K: AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS

Apr 27, 2023 16:11 ET